BE819294A - Nouvelles compositions pharmaceutiques contenant de l'acide n-(2-furfuryl)-4-chloro-5-sulfamoyl-antranilique et leur procede de preparation - Google Patents

Nouvelles compositions pharmaceutiques contenant de l'acide n-(2-furfuryl)-4-chloro-5-sulfamoyl-antranilique et leur procede de preparation

Info

Publication number
BE819294A
BE819294A BE147988A BE147988A BE819294A BE 819294 A BE819294 A BE 819294A BE 147988 A BE147988 A BE 147988A BE 147988 A BE147988 A BE 147988A BE 819294 A BE819294 A BE 819294A
Authority
BE
Belgium
Prior art keywords
furfuryl
sulfamoyl
chloro
pharmaceutical compositions
preparation process
Prior art date
Application number
BE147988A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5890849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE819294(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of BE819294A publication Critical patent/BE819294A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE147988A 1973-08-28 1974-08-28 Nouvelles compositions pharmaceutiques contenant de l'acide n-(2-furfuryl)-4-chloro-5-sulfamoyl-antranilique et leur procede de preparation BE819294A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2343218A DE2343218C2 (de) 1973-08-28 1973-08-28 Furosemid enthaltende Pellets

Publications (1)

Publication Number Publication Date
BE819294A true BE819294A (fr) 1975-02-28

Family

ID=5890849

Family Applications (1)

Application Number Title Priority Date Filing Date
BE147988A BE819294A (fr) 1973-08-28 1974-08-28 Nouvelles compositions pharmaceutiques contenant de l'acide n-(2-furfuryl)-4-chloro-5-sulfamoyl-antranilique et leur procede de preparation

Country Status (17)

Country Link
US (1) US4324779A (nl)
JP (1) JPS563849B2 (nl)
AT (1) AT344914B (nl)
BE (1) BE819294A (nl)
CA (1) CA1063024A (nl)
DE (1) DE2343218C2 (nl)
DK (1) DK155173B (nl)
EG (1) EG14662A (nl)
FI (1) FI249774A (nl)
FR (1) FR2242076B1 (nl)
GB (1) GB1478715A (nl)
HU (1) HU171769B (nl)
IL (1) IL45521A (nl)
MX (1) MX3585E (nl)
NL (1) NL7411269A (nl)
SE (1) SE7410788L (nl)
ZA (1) ZA745443B (nl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1086226A (en) * 1976-11-26 1980-09-23 Yegnaswami Raghunathan Ion exchange resin prolonged release pharmaceutical preparations
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4773907A (en) * 1982-12-20 1988-09-27 Alza Corporation Primary delivery system comprising secondary dosage form
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
DE3305935C2 (de) * 1983-02-21 1985-05-30 Medice Chem.-Pharm. Fabrik Pütter GmbH & Co KG, 5860 Iserlohn Kaliumneutrales Saluretikum mit antihypertensiver Wirkung
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
US4663348A (en) * 1985-07-02 1987-05-05 Warner-Lambert Co. Furosemide salts and pharmaceutical preparations thereof
SE460947B (sv) * 1986-08-26 1989-12-11 Lejus Medical Ab En multiple-unit-dos komposition av l-dopa
JPH01130957U (nl) * 1988-02-29 1989-09-06
JPH0710747A (ja) * 1993-04-28 1995-01-13 Takeda Chem Ind Ltd 固形製剤およびその製造方法
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
US20070059358A1 (en) * 2003-07-02 2007-03-15 Tianjin Tasly Pharmaceutical Co., Ltd., China Matrix adjuvants and the drop pills prepared with them

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3361632A (en) * 1964-05-08 1968-01-02 Hoechst Ag Medicinal preparations having a protracted activity and method of making them
US3456049A (en) * 1965-05-25 1969-07-15 Ciba Geigy Corp Gradual-release tablet
US3857933A (en) * 1969-10-17 1974-12-31 Hoechst Ag Process for the manufacture of a drug dosage form permitting controlled release of active ingredient
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung

Also Published As

Publication number Publication date
FR2242076A1 (nl) 1975-03-28
CA1063024A (en) 1979-09-25
MX3585E (es) 1981-03-20
DE2343218C2 (de) 1986-08-07
AT344914B (de) 1978-08-25
GB1478715A (en) 1977-07-06
IL45521A (en) 1978-07-31
NL7411269A (nl) 1975-03-04
DE2343218A1 (de) 1975-04-03
FR2242076B1 (nl) 1978-07-28
JPS563849B2 (nl) 1981-01-27
IL45521A0 (en) 1974-11-29
DK455274A (nl) 1975-04-28
ZA745443B (en) 1975-08-27
HU171769B (hu) 1978-03-28
FI249774A (nl) 1975-03-01
SE7410788L (nl) 1975-03-03
ATA694274A (de) 1977-12-15
EG14662A (en) 1984-09-30
AU7272874A (en) 1976-03-04
DK155173B (da) 1989-02-27
JPS5076217A (nl) 1975-06-21
US4324779A (en) 1982-04-13

Similar Documents

Publication Publication Date Title
FR2293928A1 (fr) Nouveaux derives d'acide 3-amino-indazolecarboxylique, leur procede de preparation et medicament les contenant
BE830211A (fr) Nouveaux amides d'acides carboxyliques, leur procede de preparation etmedicament les contenant
BE827777A (fr) Nouveaux amides d'acides carboxyliques, leur procede de preparation et medicament les contenant
BE832332A (fr) Nouveaux derives de l'acide 3-quinoleine carboxylique, procede de preparation et compositions pharmaceutiques
FR2281340A1 (fr) Derives de l'acide folique, leur procede de preparation et leur application
FR2351651A1 (fr) Nouvelles guanidines, leur procede de preparation et composition pharmaceutique les contenant
BE819294A (fr) Nouvelles compositions pharmaceutiques contenant de l'acide n-(2-furfuryl)-4-chloro-5-sulfamoyl-antranilique et leur procede de preparation
BE755924A (fr) Derives d'acide pyrazole-4-acetique, leur procede de preparation et medicaments en contenant
BE818209A (fr) Derives de l'acide 7-acylamino-3-cephene-4-carboxylique et leur procede de preparation
BE865299A (fr) Nouvelles oximes derivees de l'acide 7-amino-thiazolyl acetamido cephalosporanique, procede de preparation et compositions pharmaceutiques
BE822496A (fr) Derives d'acide hydratropique et leur procede de preparation
BE823692A (fr) Nouveaux derives d'acide prostanoique et leur procede de preparation
BE809179A (fr) Nouvelles cyclopropylamines, leur procede d'obtention et les compositions pharmaceutiques en contenant
BE840469A (fr) Nouveaux amides d'acides carboxyliques, leur procede de preparation etmedicament les contenant
BE803474A (fr) Nouvelles 2-alkylamino-dihydropyridines, leur procede de preparation et compositions pharmaceutiques les contenant
BE819890A (fr) Nouveaux derives d'acide pyrazolyloxyacetique et leur procede de preparation
FR2286643A1 (fr) Nouveaux triiodocarbanilates, leur procede de preparation et composition pharmaceutique les contenant
BE831298A (fr) Nouveaux derives d'acide prostanoique et leur procede de preparation
BE815742A (fr) Nouveaux derives d'acide prostanoique et leur procede de preparation
BE842832A (fr) Nouveaux derives de l'acide aminobenzoique, procede pour leur preparation et composition pharmaceutique en contenant
FR2315910A1 (fr) Compositions pharmaceutiques contenant de la " debrycine " heterocolloidale et procede pour leur preparation
FR2281109A1 (fr) Amides de l'acide cinnamique, leur preparation et medicament contenant ces substances
FR2274291A1 (fr) Nouvelles compositions pharmaceutiques et procede pour leur preparation
BE835744A (fr) Derives de 5,7-dihydroxytetraisoquinoline, procede pour leur preparation et compositions pharmaceutiques contenant de tels derives
BE799144A (fr) Nouveaux acylamino acides, leur procede d'obtention et les compositions pharmaceutiques en renfermant

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: HOECHST A.G.

Effective date: 19940828